Other neurological symptoms such as peripheral neuropathy, paresthesias, or allodynia have not been consistently reported as adverse effects attributable to semaglutide in controlled trials
In clinical studies of GLP-1RA plus SGLT2i combination therapy, the safety profile of the combination therapy was consistent with those of the individual agents, with no unexpected findings [9]
Disguised Alpha approaches GLP products with a higher standard: cGMP production where applicable, batch-level review, internal quality control, professional storage, and direct fulfillment oversight
Challenges and Side Effects Despite their benefits, GLP-1 receptor agonists come with certain challenges: Gastrointestinal Issues: Nausea, vomiting, diarrhoea, and constipation are common side effects